OCC 2.82% 36.5¢ orthocell limited

30 million would be well suited for future trials and...

  1. 757 Posts.
    lightbulb Created with Sketch. 120
    30 million would be well suited for future trials and manufacturing expansion. It would be crazy to waste a cent of it on a buy back. If revenues sky-rocket then it changes everything but in my opinion we will struggle to go cash flow positive in the next two years alone.
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
0.010(2.82%)
Mkt cap ! $76.40M
Open High Low Value Volume
36.0¢ 37.0¢ 36.0¢ $64.31K 175.5K

Buyers (Bids)

No. Vol. Price($)
2 26656 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 48304 2
View Market Depth
Last trade - 16.10pm 01/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.